A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks, including ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
In 2023, Moderna initiated a Phase 1/2 study to generate safety and immunogenicity data of an investigational pandemic influenza vaccine (mRNA-1018) in healthy adults aged 18 years and older.
The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu vaccine development. The vaccine aims to combat current bird flu strains in ...
In order to combat “multiple health threats,” the agency added that Moderna will design up to four additional pandemic influenza vaccines for testing in Phase 1 clinical trials. It may sound ...